AI and Machine Learning in Process Chromatography: Optimising Purification for Biologics Manufacturing

Process chromatography in biologics manufacturing sits at an unusual intersection of analytical science and industrial economics. AI process chromatography for biological applications is attracting serious investment precisely because the stakes are high on both dimensions: a batch failure or a prematurely retired resin in a monoclonal antibody purification process is expensive in a way that errors in most analytical contexts are not. Machine learning is entering this space through several routes, from predictive models for resin lifetime and loading optimisation to AI-assisted real-time process monitoring, and the applications are maturing fast enough that downstream process scientists need a practical map of what is actually deployable now.

This guide covers that map. It stays deliberately in the downstream purification and analytical characterisation lane: distinct from drug discovery applications and from the analytical method development coverage in the AI in analytical science overview. For a detailed look at the analytical side of Protein A chromatography specifically, the existing guide to Protein A optimisation for complex monoclonal antibodies provides complementary depth.

Working in analytical science?

Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.

Subscribe for free

Why Biologics Purification Is an AI Opportunity

The economic case for AI in downstream bioprocessing is unusually straightforward. Estimates vary with how the accounting is drawn, but chromatography represents a substantial share of downstream processing costs in monoclonal antibody production, by some analyses up to 60 percent, with Protein A affinity resin widely identified as the dominant single cost driver. A resin that is retired too early wastes a substantial capital investment; one that is run beyond its reliable useful life risks product quality failures that carry regulatory and commercial consequences far exceeding the cost of the resin itself. Machine learning that can predict with greater accuracy when a resin will fail, or what loading conditions will maximise yield before that failure, has a clear and calculable return.

Beyond cost, process chromatography is analytically well suited to machine learning for a reason that matters to separation scientists: it generates large, structured, time-series data from every run. UV absorbance traces, conductivity, pH, pressure, and flow rate are logged continuously, and that record, accumulated across hundreds or thousands of cycles, is exactly the kind of training data that predictive models need. The challenge is not finding data; it is curating, annotating, and connecting it across scales and between sites.

The economic case for AI in downstream bioprocessing is unusually straightforward. Chromatography is one of the largest downstream cost centres in mAb manufacturing, by some analyses up to 60 percent. Models that predict when a resin will fail or how to load it for maximum yield have a calculable return before a single pilot run is done.

AI-Assisted Loading and Gradient Optimisation

Loading optimisation in process chromatography is fundamentally a problem of predicting dynamic binding capacity (DBC) under varying feed composition and operating conditions, and then using that prediction to set loading volumes that maximise yield while maintaining product quality. A 2024 study in Biochemical Engineering Journal demonstrated a deep learning-based convolutional neural network approach that predicted Protein A elute concentration and aggregate percentages from routinely collected process data, achieving a mean percentage deviation of under 3 percent in experimental validation, a level of accuracy that makes the model practically useful for process decisions rather than only illustrative.

What AI-assisted loading optimisation changes in practice:

• Dynamic binding capacity modelling. ML models trained on historical runs can predict DBC as a function of feed titre, flow rate, and column history, allowing loading volumes to be adjusted dynamically rather than fixed conservatively based on worst-case assumptions.
• Wash and elution optimisation. The same modelling approach extends to wash and elution conditions, predicting the salt and pH gradients that will maximise yield and purity for a given feed, reducing the experimental burden of process characterisation.
• Pool collection decisions. AI models applied to real-time UV and conductivity data can support decisions about when to start and stop fraction collection, improving yield consistency across cycles and feed variability.
• Host cell protein clearance prediction. Predictive models for HCP clearance, trained on the correlation between process conditions and downstream HCP assay results, can flag batches likely to fail specifications before time-consuming HCP assays are complete.

The gradient optimisation approach also connects directly to the analytical method development tools covered in the broader AI in analytical science overview, but applied at process scale, the models are trained on process data rather than analytical-scale chromatograms, and the acceptance criteria are product quality attributes rather than analytical resolution.

Resin Lifetime Prediction With Machine Learning

Resin lifetime prediction is the most commercially mature AI application in process chromatography. The underlying problem, determining when a resin's performance has degraded to a point that it should be retired, has historically been managed either by conservative fixed-cycle limits (costly in resin terms) or by time-consuming offline characterisation assays (costly in operational terms). Machine learning offers a third path: predicting remaining useful lifetime from the performance data the process generates anyway.

A comprehensive review of predictive models for chromatography-based purification from the Fraunhofer Institute and RWTH Aachen mapped the performance indicators that carry the most predictive weight for resin degradation: dynamic binding capacity decline, pressure drop increase across the column bed, UV baseline drift indicating ligand leaching, and changes in product recovery and purity trends. Models trained on these indicators over hundreds of cycles can identify degradation trajectories before they cross specification limits.

What this means for resin management in practice:

• Earlier, more accurate replacement decisions. Rather than retiring a resin at a fixed cycle number chosen to guarantee a safety margin, ML predictions allow retirement when the model forecasts the resin is approaching its limit, extending useful life while maintaining the same safety level.
• Site-specific calibration. Resin degradation rate depends on feed composition, cleaning regime, and storage conditions, all of which vary between manufacturing sites. Models calibrated to site-specific process data outperform generic lifetime curves.
• Integration with process data systems. The value of resin lifetime models depends on continuous data ingestion from the process information management system. The data infrastructure question is at least as important as the model architecture.
• Regulatory documentation. Any AI-based resin retirement decision in a GMP environment requires a validated model, documented acceptance criteria, and an audit trail for each cycle assessment. The compliance infrastructure should be designed before the model is deployed, not retrofitted afterward.

Real-Time Process Monitoring and PAT Integration

Process analytical technology, the FDA's framework for science and risk-based manufacturing introduced in its 2004 PAT guidance, established the regulatory vision for real-time process understanding and control in biopharmaceutical manufacturing. AI is finally making that vision technically feasible at the complexity level that process chromatography demands. A 2025 review in Analytical Science Advances, covering the current PAT landscape in downstream bioprocessing, describes how integration of inline and online analytical techniques with AI-based process monitoring systems is enabling early deviation detection and tightening the feedback loop between measurement and process decision.

The key sensor types feeding AI monitoring models:

• Inline UV absorbance. Continuous measurement of UV absorbance at 280 nm and at product-specific wavelengths enables real-time tracking of protein concentration, pool boundaries, and breakthrough detection, the most widely deployed inline analytical tool in chromatographic purification.
• Inline Raman spectroscopy. Provides richer chemical information than UV alone, enabling online monitoring of product concentration and quality attributes without sampling, particularly valuable for polishing steps where impurity profiles evolve across the elution gradient.
• Conductivity and pH sensors. Standard process sensors whose real-time profiles, when modelled with ML rather than simply logged, carry information about column bed condition, buffer preparation consistency, and incipient deviations before they become visible on the UV trace.
• Multivariate process monitoring. Combining several sensor streams in a multivariate model, using PCA or ML-based approaches, detects deviations that no single sensor would flag independently, the application that most directly translates PAT's promise into manufacturing practice.

The regulatory implication is important: FDA's PAT framework explicitly supports real-time release testing and process endpoint determination based on validated process analytical models. AI-assisted process monitoring that is properly validated and integrated into the quality system is not just operationally valuable; it is the direction FDA has signalled for modern biopharmaceutical manufacturing.

PAT, Continuous Chromatography, and AI-Enabled Control

Continuous chromatography, multi-column periodic counter-current systems, and BioSMB-type integrated processes generate a data volume and a process complexity that makes AI-assisted control practically necessary rather than merely useful. In a conventional batch Protein A step, process decisions are relatively simple: load, wash, elute, clean. In a continuous chromatography system with four to six columns operating simultaneously in overlapping phases, the decision space is orders of magnitude larger.

Where AI contributes to continuous process management:

• Cycle timing and column switching. AI models trained on product breakthrough profiles and column performance histories can optimise the timing of column switching in real time, maximising capacity utilisation while preventing breakthrough losses.
• Predictive deviation detection. With multiple columns running simultaneously, a performance deviation in one column propagates differently than in a batch system. AI monitoring that tracks each column's contribution to the pool quality and flags asymmetries early provides a level of process visibility that manual monitoring cannot match at this data density.
• Control integration. The combination of real-time inline analytics, AI deviation detection, and control system integration, where the AI model's output feeds directly into automated pump speed or valve timing adjustments, represents the frontier of PAT-enabled manufacturing. This level of closed-loop control is deployed in leading facilities and represents the practical realisation of FDA's PAT vision.

Scale-Up: How AI Models Transfer From Lab to Manufacturing

Scale-up is where AI models in process chromatography face their most demanding test. A predictive model trained on lab-scale column data, typically 1 mL to 1 L resin bed volumes, does not automatically apply to manufacturing-scale columns of 10 L to 500 L or larger. The flow dynamics, mass transfer characteristics, and packing behaviour of large-scale columns differ from small-scale columns in ways that are understood theoretically but challenging to capture in data-driven models.

The scale-up challenges that matter most for AI models:

• Column packing heterogeneity. Large-scale columns exhibit greater bed heterogeneity than bench-scale columns, which affects zone spreading and peak shape in ways that lab-scale models do not predict well. Models that account for scale-dependent packing behaviour require deliberate design.
• Mass transfer at scale. Diffusion-limited mass transfer effects, which are modest at bench scale, can become significant at manufacturing scale with some resin bead sizes and flow rates, shifting the optimal loading conditions compared to small-scale predictions.
• Hybrid modelling approaches. The most productive current direction is hybrid models that combine mechanistic chromatography theory with machine learning, using the physics model to constrain predictions in the regions of operation where data is sparse, and the ML layer to capture process-specific deviations from the theoretical ideal.
• Transfer learning. Adapting a model trained on one scale or site to a new context using a small amount of target-domain data, a technique borrowed from other ML fields, is being actively explored for chromatography scale-up and site transfer applications.

Scale-up model transfer is not a solved problem, and approaches that work well for one product and process may not generalise to others. The practical guidance is to treat lab-scale models as inputs to scale-up rather than direct predictions, and to plan for a recalibration phase at each scale transition using process data collected at that scale. ICH Q14's framework for analytical procedure development and its lifecycle approach to method validation provides a useful governance model for how these transitions should be documented.

This article was produced under Separation Science’s AI Editorial Guidelines